Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Effects of Medicare Part D Coverage Gap on Medication and Medical Treatment Among Elderly Beneficiaries With Depression

Effects of Medicare Part D Coverage Gap on Medication and Medical Treatment Among Elderly... ORIGINAL ARTICLE Effects of Medicare Part D Coverage Gap on Medication and Medical Treatment Among Elderly Beneficiaries With Depression Yuting Zhang, PhD; Seo Hyon Baik, PhD; Lei Zhou, MS; Charles F. Reynolds III, MD; Judith R. Lave, PhD Context: Maintenance antidepressant pharmaco- Results: Being in the gap was associated with compa- rable reductions in the use of antidepressants, heart fail- therapy in late life prevents recurrent episodes of major ure medications, and antidiabetics. Relative to the com- depression. The coverage gap in Medicare Part D could parison group (those who had full coverage in the gap increase the likelihood of reducing appropriate use of an- because of Medicare coverage or low-income subsidies), tidepressants, thereby exposing older adults to an in- the no-coverage group reduced their monthly antidepres- creased risk for relapse of depressive episodes. sant prescriptions by 12.1% (95% CI, 9.9%-14.3%) from the pregap level, whereas they reduced use of heart failure Objectives: To determine whether (1) beneficiaries drugs and antidiabetics by 12.9% and 13.4%, respectively. reduce antidepressant use in the gap, (2) the reduction Those with generic drug coverage in the gap reduced their in antidepressant use is similar to the reduction in heart monthly antidepressant prescriptions by http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Psychiatry American Medical Association

Effects of Medicare Part D Coverage Gap on Medication and Medical Treatment Among Elderly Beneficiaries With Depression

Loading next page...
 
/lp/american-medical-association/effects-of-medicare-part-d-coverage-gap-on-medication-and-medical-V7k1kcIxnj
Publisher
American Medical Association
Copyright
Copyright 2012 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-622X
eISSN
2168-6238
DOI
10.1001/archgenpsychiatry.2011.1402
pmid
22752233
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Effects of Medicare Part D Coverage Gap on Medication and Medical Treatment Among Elderly Beneficiaries With Depression Yuting Zhang, PhD; Seo Hyon Baik, PhD; Lei Zhou, MS; Charles F. Reynolds III, MD; Judith R. Lave, PhD Context: Maintenance antidepressant pharmaco- Results: Being in the gap was associated with compa- rable reductions in the use of antidepressants, heart fail- therapy in late life prevents recurrent episodes of major ure medications, and antidiabetics. Relative to the com- depression. The coverage gap in Medicare Part D could parison group (those who had full coverage in the gap increase the likelihood of reducing appropriate use of an- because of Medicare coverage or low-income subsidies), tidepressants, thereby exposing older adults to an in- the no-coverage group reduced their monthly antidepres- creased risk for relapse of depressive episodes. sant prescriptions by 12.1% (95% CI, 9.9%-14.3%) from the pregap level, whereas they reduced use of heart failure Objectives: To determine whether (1) beneficiaries drugs and antidiabetics by 12.9% and 13.4%, respectively. reduce antidepressant use in the gap, (2) the reduction Those with generic drug coverage in the gap reduced their in antidepressant use is similar to the reduction in heart monthly antidepressant prescriptions by

Journal

JAMA PsychiatryAmerican Medical Association

Published: Jul 1, 2012

References